Become A Featured Company

Global Wellness Strategies Shanti Therapeutics Updates and Symbol Change to GWS

Ryan Allway

October 4th, 2021

Psychedelics

The Shanti Therapeutics Focus on Chronic Pain Market with Psychedelics

 

Vancouver, British Columbia–(Newsfile Corp. – October 4, 2021) – Global Wellness Strategies Inc. (CSE: LOAN) (FSE: O3X4) (OTCQB: PNNRF) (formerly Redfund Capital Corp.) (“Global” or the “Company”) changes symbol to GWS and introduces Dr. Sud Agarwal BSc, MB ChB, FANZCA, the Chairman of Cannvalate Pty Ltd. and Shanti Therapeutics. His experience and expertise in the psychedelic industry will contribute significantly to our efforts in the space moving forward.

 

GWS Symbol Change:

Global Wellness Strategies Inc. “Helping you Get Well Soon” is changing its ticker symbol from “LOAN” to “GWS“. The Company expects the symbol change to take effect on Wednesday October 6, 2021. The change in the ticker symbol is being made to provide greater visibility with respect to the long-term strategy of the Company: providing high growth companies with financial, operational, and management assistance in the fast-growing market for global wellness. No action is required by existing shareholders with regards to the ticker symbol change.

 

“We are looking forward to trading under the new ‘GWS’ symbol on the Canadian Stock Exchange,” said Meris Kott, CEO of Global Wellness Strategies. “The new symbol directly aligns with the vision of the Company and the path we foresee taking in order to continue adding significant value to our shareholders by developing and commercializing medicines with our portfolio clients.”

 

Pain & Psychedelics:

While there has been increasing hype and capital markets interest in and research on the use of psychedelics, such as psilocybin, ketamine, LSD and MDMA (aka, ecstasy or molly), for depression, anxiety, PTSD, and other psychiatric disorders, little research has been conducted to date on the use of psychedelics for chronic pain. It is the goal of the Company to be the market leader in the management of pain with IND application to the FDA for a novel drug culminating with clinical trials and changing the landscape with new solutions to solve the pain epidemic.

 

Additionally, because of the urgent need for improved pharmacological approaches for the treatment of peri-operative pain, Shanti Therapeutics has already filed a patent application outlining a method for the treatment/prevention of pain, the method comprising oral administration of an effective dose of 3,4-methylenedioxymethamphetamine (MDMA).

 

Meet the founder of Shanti Therapeutics Pty Ltd.:

Dr. Sud Agarwal is a founder and Chairman of Cannvalate Pty Ltd. based in Australia and the co-founder of Shanti Therapeutics Pty Ltd. Sud is a pioneer and a global first-mover in the novel cannabinoid space, a medical research key opinion leader and an experienced listed company executive with deep investment networks. He is also a board member and executive of a number of listed and unlisted companies.

 

Additionally, Dr. Agarwal is a board certified, specialist anesthesiologist with extensive research credentials in novel drug development and FDA registration. He is the primary inventor of > 20 novel cannabinoid and entheogen patents for a variety of medical illnesses.

 

“We are honored to work closely with Sud as a team leader at Shanti, and we look forward to his invaluable strategic advice as we continue to grow Global Wellness and enter the psychedelic industry through our definitive acquisition with Cannvalate of their subsidiary Shanti Therapeutics,” remarked Global Wellness Strategies CEO, Meris Kott.

 

About Global Wellness Strategies

Global Wellness Strategies is a prospect generator that provides high growth companies with financial, operational, and management assistance in the fast-growing market for wellness consumer products. The focus of the Company is on global wellness, psychedelics, mycology, hemp and CBD, healthcare-related target companies.

 

For further information visit websites:
www.globalwellnessstrategies.com and www.shantitherapeutics.com

Or Contact Meris Kott CEO 604.484.0355 or email to info@globalwellnessstrategies.com

Further information about the Company is available on www.SEDAR.com under the Company’s profile.

 

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements contained in this release may constitute “forward-looking statements” or “forward-looking information” (collectively “forward-looking information”) as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated”, “anticipates” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, its financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading